↓ Skip to main content

Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019

Overview of attention for article published in JAMA Network Open, May 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
120 news outlets
blogs
6 blogs
policy
1 policy source
twitter
42 X users

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019
Published in
JAMA Network Open, May 2021
DOI 10.1001/jamanetworkopen.2021.4920
Pubmed ID
Authors

Beth I. Wallace, Brooke Kenney, Preeti N. Malani, Daniel J. Clauw, Brahmajee K. Nallamothu, Akbar K. Waljee

X Demographics

X Demographics

The data shown below were collected from the profiles of 42 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 14%
Student > Ph. D. Student 4 11%
Researcher 4 11%
Student > Doctoral Student 3 8%
Other 2 6%
Other 6 17%
Unknown 12 33%
Readers by discipline Count As %
Medicine and Dentistry 9 25%
Biochemistry, Genetics and Molecular Biology 3 8%
Nursing and Health Professions 3 8%
Unspecified 2 6%
Agricultural and Biological Sciences 2 6%
Other 3 8%
Unknown 14 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 998. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 September 2023.
All research outputs
#16,254
of 25,498,750 outputs
Outputs from JAMA Network Open
#179
of 9,684 outputs
Outputs of similar age
#679
of 457,445 outputs
Outputs of similar age from JAMA Network Open
#14
of 465 outputs
Altmetric has tracked 25,498,750 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,684 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 129.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 457,445 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 465 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.